Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

335
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
335
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

876
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
876
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

7.1K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.1K
Vascular Spasm01:16

Vascular Spasm

2.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
2.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.1K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

898
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
898

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe Dyslipidemia.

Pediatric cardiology·2026
Same author

Fecal Lipid Metabolites and Microbiota Alterations in Dogs With Concurrent Atopic Dermatitis and Adverse Food Reaction.

Allergy·2026
Same author

Urinary prostaglandin D<sub>2</sub> metabolite as a potential diagnostic biomarker for perioperative anaphylaxis: A pilot study.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Development of an Enzyme Immunoassay for Detecting Urinary Tetranor-PGDM in Patients With Food Allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Unveiling heterogeneity in individual thresholds: validation using urinary prostaglandin D<sub>2</sub> metabolite in food allergy reactions.

Allergologia et immunopathologia·2026
Same author

Interactions between atomic-scale skyrmions in 2D chiral magnets.

Scientific reports·2026

Related Experiment Video

Updated: Dec 2, 2025

Microperfusion Technique to Investigate Regulation of Microvessel Permeability in Rat Mesentery
12:48

Microperfusion Technique to Investigate Regulation of Microvessel Permeability in Rat Mesentery

Published on: September 12, 2015

10.0K

[Prostanoids regulate vascular permeability].

Daiki Horikami1, Koji Kobayashi1, Takahisa Murata1

  • 1Department of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo.

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|November 2, 2020
PubMed
Summary
This summary is machine-generated.

Prostanoids, lipid mediators, regulate vascular permeability by influencing endothelial and mural cells. Understanding their specific receptor interactions is key to controlling inflammation and its associated vascular changes.

More Related Videos

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
08:43

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

Published on: June 19, 2018

15.6K
An in vivo Assay to Test Blood Vessel Permeability
07:03

An in vivo Assay to Test Blood Vessel Permeability

Published on: March 16, 2013

66.3K

Related Experiment Videos

Last Updated: Dec 2, 2025

Microperfusion Technique to Investigate Regulation of Microvessel Permeability in Rat Mesentery
12:48

Microperfusion Technique to Investigate Regulation of Microvessel Permeability in Rat Mesentery

Published on: September 12, 2015

10.0K
Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
08:43

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

Published on: June 19, 2018

15.6K
An in vivo Assay to Test Blood Vessel Permeability
07:03

An in vivo Assay to Test Blood Vessel Permeability

Published on: March 16, 2013

66.3K

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Physiology

Background:

  • Vascular permeability increases during inflammation, allowing larger molecules to pass through, exacerbating inflammatory responses.
  • The precise mechanisms governing vascular permeability, controlled by endothelial and mural cells, remain incompletely understood.
  • Prostanoids, lipid mediators binding to G protein-coupled receptors (GPCRs), are increasingly recognized for their role in regulating vascular permeability.

Purpose of the Study:

  • To review the role of individual prostanoids in regulating vascular permeability.
  • To elucidate how prostanoids interact with specific prostanoid receptors on endothelial and vascular mural cells.
  • To highlight the mechanisms by which prostanoids influence vascular barrier function.

Main Methods:

  • Literature review of studies investigating prostanoids and vascular permeability.
  • Analysis of research on prostanoid receptor signaling pathways.
  • Synthesis of findings on the cellular effects of prostanoids on endothelial and mural cells.

Main Results:

  • Prostanoids modulate vascular permeability through actions on both endothelial cells and vascular mural cells.
  • Specific prostanoid receptors mediate distinct effects on endothelial barrier integrity and vascular tone.
  • The balance between endothelial barrier function and vascular smooth muscle contraction, influenced by prostanoids, dictates overall vascular permeability.

Conclusions:

  • Prostanoids are critical regulators of vascular permeability during inflammation.
  • Targeting specific prostanoid-receptor interactions offers potential therapeutic strategies for inflammatory diseases.
  • Further research into prostanoid signaling pathways is essential for a comprehensive understanding of vascular homeostasis.